Activation of neurogenesis improves amyloid-β pathology and cognitive function through AMP kinase signaling in Alzheimer's disease model mice
Masahiro Fukui, Takashi Kaise, Taimu Masaki, Tyler Sakamoto, Ryoichiro Kageyama
The paper shows that iPaD treatment and Prkag2 knockdown enhance neurogenesis and reduce amyloid-β in Alzheimer's disease model mice by activating AMP kinase signaling.
Cell Reports · Apr 1, 2026Peer-reviewedNeuroscience